Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2024 Nov 26;16(11):956–973. doi: 10.4252/wjsc.v16.i11.956

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.

This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.

PMC Copyright notice

Spheroid-based and in vivo assessment of small interfering peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 RNA-loaded soluble a proliferation-inducing ligand-targeted exosome efficacy in HCT116 models. A: Effects of exosomes (Ex) loaded with siPIN1 (Ex[p]) and small interfering peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 RNA-loaded soluble a proliferation-inducing ligand-targeted exosome (tEx[p]) on cell viability in HCT116-derived spheroids. Fluorescence microscopy images illustrate cell viability after treatments. Cells were stained using a LIVE/DEAD staining kit to distinguish live cells (green) from dead cells (red) (left panel). Representative images of spheroids treated with negative control, Ex[p], and tEx[p] (right panel). Quantification of the dead/live ratio, showing a significant increase in cell death in the tEx[p] treated spheroids compared to Ex[p] treated ones. This increase suggests that tEx[p] could also affect the viability of cancer stem cells within the spheroids, indicating its potential efficacy against tumor resilience. Error bars denote standard deviation based on three independent experiments; B: Immunofluorescence analysis of cancer stem cell markers CD44 and CD133 in spheroids treated with Ex[p] and tEx[p] for 24 hours. The expression of CD44 (red) and CD133 (green) is reduced in tEx[p] treated spheroids compared to Ex[p] treated spheroids, indicating a decrease in cancer stem cell populations. Nuclei are counterstained with DAPI (blue). Images are representative of three independent experiments; C: Xenograft appearance and size comparison in each group; D: Comparision of body weight measurements, demonstrating no significant weight differences among the groups, suggesting minimal systemic toxicity; E: Measurements of tumor volumes. The tEx[p] group demonstrated the smallest tumor volumes in the comparison of tumor sizes; F: Measurements of tumor volumes on day 20 post-treatment. The tEx[p] group exhibited significantly reduced tumor weights compared to other groups in the tumor weight comparison. ^aP < 0.05, ^bP < 0.01.